GlobeNewswire

Overall Survival by Line of Therapy (n=28)

Overall Survival by Line of Therapy (n=28)

As of Jan 6, 2019; evaluable patients include patients completing one cycle of therapy
Tyme Technologies, Inc.
Format

JPEG

Source

Tyme Technologies, Inc.

Downloads